Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen McIlleron

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
British Journal of Clinical Pharmacology|January 19, 2022
Treating children with tuberculosis-Using pharmacometrics to do betterHelen McIlleron
Expert Review of Anti-Infective Therapy|December 4, 2018
Current research toward optimizing dosing of first-line antituberculosis treatmentHelen McIlleron, Maxwell T Chirehwa
Biostatistics (Oxford, England)|November 18, 2024
Recoverability of causal effects under presence of missing data: a longitudinal case studyAnastasiia Holovchak, Helen McIlleron, Paolo Denti, et al.
Statistics in Medicine|October 18, 2024
Causal Inference for Continuous Multiple Time Point InterventionsMichael Schomaker, Helen McIlleron, Paolo Denti, et al.
The Journal of Infectious Diseases|August 30, 2007
Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndromeHelen McIlleron, Graeme Meintjes, William J Burman, et al.
Journal of Clinical Pharmacology|July 26, 2017
A Review of Moxifloxacin for the Treatment of Drug-Susceptible TuberculosisAnushka Naidoo, Kogieleum Naidoo, Helen McIlleron, et al.
Expert Review of Anti-Infective Therapy|May 31, 2019
Quantitative assessment of the activity of antituberculosis drugs and regimensMaxwell T Chirehwa, Gustavo E Velásquez, Tawanda Gumbo, et al.
Antimicrobial Agents and Chemotherapy|August 6, 2014
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapyTawanda Gumbo, Jotam G Pasipanodya, Peter Wash, et al.
Lancet (London, England)|May 22, 2010
Global tuberculosis drug development pipeline: the need and the realityZhenkun Ma, Christian Lienhardt, Helen McIlleron, et al.
Drug Discovery Today|November 13, 2007
Combined therapy for tuberculosis and HIV-1: the challenge for drug discoveryDominique J Pepper, Graeme A Meintjes, Helen McIlleron, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
British Journal of Clinical Pharmacology|January 19, 2022
Treating children with tuberculosis-Using pharmacometrics to do betterHelen McIlleron
Expert Review of Anti-Infective Therapy|December 4, 2018
Current research toward optimizing dosing of first-line antituberculosis treatmentHelen McIlleron, Maxwell T Chirehwa
Biostatistics (Oxford, England)|November 18, 2024
Recoverability of causal effects under presence of missing data: a longitudinal case studyAnastasiia Holovchak, Helen McIlleron, Paolo Denti, et al.
Statistics in Medicine|October 18, 2024
Causal Inference for Continuous Multiple Time Point InterventionsMichael Schomaker, Helen McIlleron, Paolo Denti, et al.
The Journal of Infectious Diseases|August 30, 2007
Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndromeHelen McIlleron, Graeme Meintjes, William J Burman, et al.
Journal of Clinical Pharmacology|July 26, 2017
A Review of Moxifloxacin for the Treatment of Drug-Susceptible TuberculosisAnushka Naidoo, Kogieleum Naidoo, Helen McIlleron, et al.
Expert Review of Anti-Infective Therapy|May 31, 2019
Quantitative assessment of the activity of antituberculosis drugs and regimensMaxwell T Chirehwa, Gustavo E Velásquez, Tawanda Gumbo, et al.
Antimicrobial Agents and Chemotherapy|August 6, 2014
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapyTawanda Gumbo, Jotam G Pasipanodya, Peter Wash, et al.
Lancet (London, England)|May 22, 2010
Global tuberculosis drug development pipeline: the need and the realityZhenkun Ma, Christian Lienhardt, Helen McIlleron, et al.
Drug Discovery Today|November 13, 2007
Combined therapy for tuberculosis and HIV-1: the challenge for drug discoveryDominique J Pepper, Graeme A Meintjes, Helen McIlleron, et al.
Pageof 15